Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Orgovyx
Orgovyx
Sumitomo nets Myovant in $2.9B buyout, adding IVF asset to pipeline
Fierce Biotech
Mon, 10/24/22 - 11:20 pm
Sumitomo Pharma
M&A
Myovant
IVF
In Vitro Fertilization
Orgovyx
Myfembree
Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug
TheStreet.com
Mon, 12/28/20 - 10:42 am
Myovant
Pfizer
prostate cancer
Orgovyx
Relugolix
In groundbreaking move, FDA approves Myovant's relugolix as the first once-a-day pill for advanced prostate cancer
Endpoints
Sat, 12/19/20 - 11:24 pm
Myovant Sciences
Relugolix
FDA
prostate cancer
Orgovyx